Board Member
Board member since
2026
Nationality
Danish
Born
1971
Non-independent
Board committees, LEO Pharma
Member of the Innovation Committee.
Positions and management duties
Board member of LEO Foundation and LEO Holding.
Career
Former Executive Vice President, Research and Development at ALK-Abelló A/S and Corporate Project Vice President, Rare Disease & Advanced Therapies, R&D, at Novo Nordisk A/S. Doctor of Medicine and a Ph.D. in Medicine from the University of Copenhagen, along with a degree in Pharmaceutical Medicine from the University of Basel. Completed the Executive Board Programme at INSEAD and the Scandinavian Management Institute.
Special competencies
Extensive experience in global product development, portfolio and pipeline management, business development and M&A, regulatory strategy, and board-level reporting and governance. Acquired through senior leadership roles such as Executive Vice President at ALK-Abelló A/S and Corporate Project Vice President at Novo Nordisk A/S.
Meet our Board of Directors
The Board of Directors is accountable for LEO Pharma’s corporate governance, strategic direction, and long-term sustainability.
